Several studies have demonstrated that memory T cells including stem cell memory (Tscm)
T cells and central memory (Tcm) T cells show superior persistence and antitumor immunity …

Patients with cancer can develop recurrent metastatic disease with latency periods that
range from years even to decades. This pause can be explained by cancer dormancy, a …

Microwave ablation (MWA) as a local tumor ablation strategy suffers from posttreatment
tumor recurrence. Development of adjuvant biomaterials to potentiate MWA is therefore of …

Tumor angiogenesis is recognized as a major therapeutic target in the fight against cancer.
The key involvement of angiogenesis in tumor growth and metastasis has started to redefine …

Early spread of tumor cells is usually undetected by current imaging technologies. In
patients with cancer and no signs of overt metastases sensitive methods have been …

Despite increased focus on the clinical relevance of dormant metastatic disease, our
understanding of dormant niches, mechanisms underlying emergence from dormancy, and …

This brief review discusses the role of the immune system in tumor development, covering a
history of cancer immunity and a summary of the concept of cancer immunoediting, including …

Cancer cell dormancy is a common feature of human tumors and represents a major clinical
barrier to the long-term efficacy of anticancer therapies. Dormant cancer cells, either in …

Systemic minimal residual disease after primary tumor treatment can remain asymptomatic
for decades. This is thought to be due to the presence of dormant disseminated tumor cells …

Metastasis accounts for the vast majority of morbidity and mortality associated with
melanoma. Evidence suggests melanoma has a predilection for metastasis to particular …